M Mohty Selected Research

M Mohty Research Topics

Disease

21	Leukemia 01/2020 - 03/2004
18	Multiple Myeloma 05/2024 - 07/2004
18	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 09/2004
11	Neoplasms (Cancer) 11/2017 - 08/2001
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 03/2004
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 03/2009
7	Lymphoma (Lymphomas) 03/2016 - 04/2000
6	Infections 04/2016 - 11/2003
5	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2018 - 06/2015
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2017 - 08/2012
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2017 - 01/2011
4	Pathologic Complete Response 12/2012 - 03/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2015
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2022 - 10/2012
3	Hodgkin Disease (Hodgkin's Disease) 10/2016 - 08/2012
3	Residual Neoplasm 12/2015 - 12/2012
3	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 08/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 02/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021 - 02/2017
2	Hematologic Diseases (Blood Diseases) 04/2016 - 02/2005
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 03/2016 - 02/2015
2	Inflammation (Inflammations) 03/2016 - 07/2013
2	Thrombocytopenia (Thrombopenia) 12/2015 - 01/2000
2	Invasive Fungal Infections 10/2012 - 03/2007
1	Fibrosis (Cirrhosis) 10/2017
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 06/2017
1	Hepatocellular Carcinoma (Hepatoma) 03/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2017
1	Mucositis 02/2017
1	Hyperglycemia 08/2016
1	Glucose Intolerance 08/2016
1	Diabetes Mellitus 08/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Breast Neoplasms (Breast Cancer) 04/2016
1	Temporal Lobe Epilepsy 04/2016

Drug/Important Bio-Agent (IBA)

5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2015 - 07/2004
4	Busulfan (Busulfex)FDA Link 09/2017 - 07/2004
3	fludarabineIBA 09/2017 - 07/2004
3	Lenalidomide (CC 5013)FDA Link 04/2016 - 02/2010
3	HLA Antigens (Human Leukocyte Antigens)IBA 09/2015 - 11/2010
2	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2022
2	SteroidsIBA 10/2017 - 10/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016 - 12/2015
2	Rituximab (Mabthera)FDA Link 09/2016 - 10/2012
2	Interleukin-22 (IL-22)IBA 03/2016 - 07/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2015 - 09/2004
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2015 - 09/2004
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2014 - 04/2005
2	Thalidomide (Thalomid)FDA Link 02/2005 - 01/2005
1	fenixIBA 05/2024
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 05/2024
1	idecabtagene vicleucelIBA 05/2024
1	B-Cell Maturation AntigenIBA 05/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2021
1	C-Reactive ProteinIBA 10/2017
1	Gemtuzumab (Mylotarg)FDA Link 04/2017
1	Sorafenib (BAY 43-9006)FDA Link 03/2017
1	Janus Kinase InhibitorsIBA 02/2017
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 02/2017
1	elotuzumabIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	PanobinostatIBA 01/2017
1	daratumumabIBA 01/2017
1	pomalidomideIBA 01/2017
1	ixazomibIBA 01/2017
1	carfilzomibIBA 01/2017
1	Brentuximab VedotinIBA 10/2016
1	ErbB Receptors (EGF Receptor)IBA 04/2016
1	gallium 68 PSMA-11IBA 04/2016
1	23-seleno-25-homotaurocholic acidIBA 04/2016
1	Dictyostelium severin protein (severin)IBA 04/2016
1	lipoarabinomannan (LAM)IBA 04/2016
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2016
1	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 04/2016
1	melanin-concentrating hormone receptorIBA 04/2016
1	multidrug resistance-associated protein 1IBA 04/2016
1	fluorocholineIBA 04/2016
1	fluoromethylcholineIBA 04/2016
1	5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA 04/2016
1	radium Ra 223 dichlorideIBA 04/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 04/2016
1	AcidsIBA 04/2016
1	AerosolsIBA 04/2016
1	Carbon MonoxideIBA 04/2016
1	Choline (Choline Chloride)IBA 04/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2016
1	Dihydroxyphenylalanine (Dopa)IBA 04/2016

Therapy/Procedure

37	Stem Cell Transplantation 01/2018 - 11/2003
30	Transplantation 01/2020 - 08/2000
19	Therapeutics 05/2024 - 08/2001
14	Hematopoietic Stem Cell Transplantation 06/2017 - 03/2009
12	Cell Transplantation 01/2024 - 04/2012
9	Drug Therapy (Chemotherapy) 09/2016 - 03/2001
5	Homologous Transplantation 12/2015 - 08/2001
4	Salvage Therapy 04/2014 - 01/2005
2	Organ Transplantation 08/2016 - 07/2007
1	Radioimmunotherapy 11/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 07/2016